Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus. 2007

Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
EPM, Universidade Federal de São Paulo, São Paulo, SP, Brazil. rdlopes@climed.epm.br

OBJECTIVE To determine the plasma homocysteine and von Willebrand factor levels as markers of endothelial dysfunction in rats with diabetes mellitus induced by streptozotocin. METHODS Thirty-five adult male rats (Rattus norvegicus albinus) (weight between 180-200 g) were randomized into three groups: control group (n=10), which received no drugs or vehicles; sham group (n=10), which received streptozotocin solution; and diabetic group (n=15), which received streptozotocin. Eight weeks after diabetes mellitus induction, the animals were weighed and anesthesized; blood samples were collected from abdominal aorta for plasma total homocysteine, von Willebrand factor and glucose levels. RESULTS The experimental model was reproducible in 100% of animals. The mean plasma homocysteine levels were: 7.9 micromol/l (control), 8.6 micromol/l (sham) and 6.1 micromol/l (diabetic), with difference among the groups (p<0.01). Multiple comparison analysis among the groups showed that values in the diabetic group were lower than in the sham group (p<0.01). The mean von Willebrand factor values were 0.15 U/l (control), 0.16 U/l (sham) and 0.18 U/l (diabetic), with difference among the groups (p=0.03). The mean value was higher in the diabetic group than in the control group (p<0.05). Correlation between homocysteine and von Willebrand factor was not observed in the diabetic group. CONCLUSIONS Reduced homocysteine levels and increased von Willebrand factor levels were observed in diabetes mellitus induced by streptozotocin; nevertheless, there were no correlations between them and with final glucose levels.

UI MeSH Term Description Entries
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D006710 Homocysteine A thiol-containing amino acid formed by a demethylation of METHIONINE. 2-amino-4-mercaptobutyric acid,Homocysteine, L-Isomer,2 amino 4 mercaptobutyric acid,Homocysteine, L Isomer,L-Isomer Homocysteine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013311 Streptozocin An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. Streptozotocin,2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose,Streptozotocine,Zanosar
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
January 1981, Hormone and metabolic research. Supplement series,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
January 1979, Metabolism: clinical and experimental,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
April 2010, Klinicheskaia laboratornaia diagnostika,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
December 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
November 2021, Scientific reports,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
May 2022, Haemophilia : the official journal of the World Federation of Hemophilia,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
December 2001, Reviews in clinical and experimental hematology,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
October 1987, Blood,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
January 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Renato Delascio Lopes, and Lindalva Batista Neves, and Vânia D'Almeida, and Gleice Margarete de Souza Conceição, and Alexandre Gabriel
January 2014, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!